汇添富中证医药ETF联接C(007077)财务指标
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 本期已实现收益 |
-4,603,070.17 |
-8,808,249.11 |
-2,789,844.65 |
-1,891,158.91 |
| 本期利润 |
3,823,453.60 |
-19,350,093.24 |
-28,791,775.23 |
-17,986,005.02 |
| 加权平均基金份额本期利润 |
0.03 |
-0.12 |
-0.19 |
-0.13 |
| 本期加权平均净值利润率(%) |
2.95 |
-14.31 |
-21.19 |
-12.92 |
| 本期基金份额净值增长率(%) |
2.63 |
-12.10 |
-18.53 |
-11.34 |
| 期末可供分配利润 |
-16,404,934.27 |
-21,600,211.76 |
-31,595,124.19 |
-3,619,802.34 |
| 期末可供分配基金份额利润 |
-0.12 |
-0.14 |
-0.20 |
-0.02 |
| 期末基金资产净值 |
122,271,794.84 |
131,718,420.90 |
123,476,421.28 |
156,688,243.72 |
| 期末基金份额净值 |
0.88 |
0.86 |
0.80 |
0.98 |
| 基金份额累计净值增长率(%) |
-11.83 |
-14.09 |
-20.37 |
-2.26 |
微信公众号
证券之星APP
基本资料
